Indian drugmaker Ranbaxy Laboratories Ltd is in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca Plc’s heartburn drug Nexium, a source said, to ensure the pills can be sold in the United States. Washington in January prohibited Ranbaxy, India’s top drugmaker by revenue, from selling drugs in the United States using ingredients from one of its plants in northern India due to poor manufacturing practices. This effectively barred it from selling drugs made in its India plants in the United States and has forced Ranbaxy to look elsewhere for supplies.
Help employers find you! Check out all the jobs and post your resume.
